Abstract
Development of a Blood biomarker for Early Detection of Pancreatic Cancer Using the Aberrant Processing of Circulating Apolipoprotein A2 Homodimers and Establishment of ‘The Platform of Evaluation for Biomarker of Cancer Early Detection (P-EBED)’ to Support Social Implementation of Early Cancer Diagnosis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
